NATALIA DE LAS
HERAS JIMÉNEZ
Profesora titular de universidad
![Foto de NATALIA DE LAS](/img/nophoto.png)
![Foto de Universidad de Salamanca](/img/noimage_org.png)
Universidad de Salamanca
Salamanca, EspañaPublications en collaboration avec des chercheurs de Universidad de Salamanca (17)
2022
-
Real-life analysis on safety and efficacy of asciminib for ponatinib pretreated patients with chronic myeloid leukemia
Annals of Hematology, Vol. 101, Núm. 10, pp. 2263-2270
2020
2017
-
Hyperdiploidy as a rare event that accompanies poor prognosis markers in CLL
European Journal of Haematology, Vol. 98, Núm. 2, pp. 142-148
-
Mutations in TP53 and JAK2 are independent prognostic biomarkers in B-cell precursor acute lymphoblastic leukaemia
British Journal of Cancer, Vol. 117, Núm. 2, pp. 256-265
2016
-
Genome-Wide DNA Copy Number Analysis of Acute Lymphoblastic Leukemia Identifies New Genetic Markers Associated with Clinical Outcome
PloS one, Vol. 11, Núm. 2, pp. e0148972
-
Minimal residual disease evaluation by flow cytometry is a complementary tool to cytogenetics for treatment decisions in acute myeloid leukaemia
Leukemia Research, Vol. 40, pp. 1-9
2015
-
Do endothelial cells belong to the primitive stem leukemic clone in CML? Role of extracellular vesicles
Leukemia Research, Vol. 39, Núm. 8, pp. 921-924
2014
-
Multiparameter flow cytometry for the identification of the Waldenström's clone in IgM-MGUS and Waldenström's Macroglobulinemia: New criteria for differential diagnosis and risk stratification
Leukemia, Vol. 28, Núm. 1, pp. 166-173
-
Mutation status and immunoglobulin gene rearrangements in patients from northwest and central region of Spain with chronic lymphocytic leukemia
BioMed Research International, Vol. 2014
2013
-
Analysis of the immune system of multiple myeloma patients achieving long-term disease control by multidimensional flow cytometry
Haematologica, Vol. 98, Núm. 1, pp. 79-86
2012
-
Incidence and clinical characteristics of myeloproliferative neoplasms displaying a PDGFRB rearrangement
European Journal of Haematology, Vol. 89, Núm. 1, pp. 37-41
-
Molecular Characterization of Chronic Lymphocytic Leukemia Patients with a High Number of Losses in 13q14
PLoS ONE, Vol. 7, Núm. 11
2011
2010
-
Risk of progression in smouldering myeloma and monoclonal gammopathies of unknown significance: Comparative analysis of the evolution of monoclonal component and multiparameter flow cytometry of bone marrow plasma cells
British Journal of Haematology, Vol. 148, Núm. 1, pp. 110-114
2009
-
Soluble and membrane levels of molecules involved in the interaction between clonal plasma cells and the immunological microenvironment in multiple myeloma and their association with the characteristics of the disease
International Journal of Cancer, Vol. 124, Núm. 2, pp. 367-375
-
The persistence of immunophenotypically normal residual bone marrow plasma cells at diagnosis identifies a good prognostic subgroup of symptomatic multiple myeloma patients
Blood, Vol. 114, Núm. 20, pp. 4369-4372
2008
-
Multiparameter flow cytometric remission is the most relevant prognostic factor for multiple myeloma patients who undergo autologous stem cell transplantation
Blood, Vol. 112, Núm. 10, pp. 4017-4023